MDT

87.92

-0.94%↓

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

MDT

87.92

-0.94%↓

115.46

-1.22%↓

VEEV

157.06

-5.63%↓

HQY

83.88

+2.36%↑

TLRY

6.71

-0.3%↓

Inicio・Lista de Acciones・Avita Therapeutics Inc

Avita Therapeutics Inc

Cerrado

4.51 9.47

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

4.09

Máximo

4.53

Métricas clave
By Trading Economics
Ingresos	1.6M -12M
Ventas	554K 18M
Margen de beneficios	-65.968
Empleados	226
EBITDA	1.6M -9.7M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+54.39% upside

Dividendos
By Dow Jones
Próximas Ganancias	7 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-4M 119M
Apertura anterior	-4.96
Cierre anterior	4.51

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

8.83 / 9.77 Soporte y Resistencia

Avita Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

10 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

ADB: Higher Energy Prices to Raise Production, Consumer Costs

10 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

ADB Projects Japan GDP Growth at 0.7% in 2026, 0.6% in 2027

10 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

ADB Projects South Korea GDP Growth at 1.9% in 2026, 1.9% in 2027

10 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

Extent of Slowdown Hinges on Duration of MidEast Conflict, ADB Says

10 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

ADB Projects India GDP Growth at 6.9% in 2026, 7.3% in 2027

10 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

ADB Projects China GDP Growth at 4.6% in 2026, 4.5% in 2027

10 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

ADB Pojects Australia GDP Grrowth at 2.0% in 2026, 2.9% in 2027

10 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

ADB Projects Taiwan GDP Growth at 7.6% in 2026, 4.0% in 2027

10 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

Geopolitical Risks Make Asia's Economic Outlook Highly Uncertain, ADB Says

10 abr 2026, 00:00 UTC

Noticias de Eventos Importantes

Asia Regional Growth Likely to Moderate in 2026-2027, ADB Says

9 abr 2026, 23:44 UTC

Charlas de Mercado

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

9 abr 2026, 23:34 UTC

Charlas de Mercado

Gold Edges Lower Amid Lingering Inflation Concerns -- Market Talk

9 abr 2026, 23:14 UTC

Charlas de Mercado

Jefferies Upbeat on Australian Miners, But Recession a Key Risk -- Market Talk

9 abr 2026, 23:14 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

9 abr 2026, 23:07 UTC

Charlas de Mercado

Centaurus's Supply Deal with Glencore Supports Jaguar Development -- Market Talk

9 abr 2026, 22:54 UTC

Charlas de Mercado

Transurban Lacks Appeal as Higher Fuel Prices Slow Traffic -- Market Talk

9 abr 2026, 22:31 UTC

Noticias de Eventos Importantes

Trump on Truth Social: 'That Is Not the Agreement We Have!'

9 abr 2026, 22:31 UTC

Noticias de Eventos Importantes

Trump on Truth Social: 'Iran Is Doing a Very Poor Job, Dishonorable Some Would Say, of Allowing Oil to Go Through the Strait of Hormuz'

9 abr 2026, 20:57 UTC

Noticias de Eventos Importantes

U.S. Oil Prices Are Back Near $100 After Israel Keeps Up Air Strikes on Lebanon -- Barrons.com

9 abr 2026, 20:55 UTC

Ganancias

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 abr 2026, 20:55 UTC

Ganancias

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 abr 2026, 20:55 UTC

Ganancias

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

9 abr 2026, 20:50 UTC

Charlas de Mercado

Energy & Utilities Roundup: Market Talk

9 abr 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

9 abr 2026, 20:40 UTC

Adquisiciones, fusiones, absorciones

Blackstone Investment Positions Rowan to Continue Delivering Sustainable Data Center Capacity for World's Leading Technology Cos >BX

9 abr 2026, 20:39 UTC

Adquisiciones, fusiones, absorciones

Blackstone Blackstone Acquired Significant Minority Stake in Rowan Digital Infrastructure >BX

9 abr 2026, 20:39 UTC

Adquisiciones, fusiones, absorciones

Rowan Digital Infrastructure Announces Strategic Recapitalization

9 abr 2026, 20:25 UTC

Adquisiciones, fusiones, absorciones

SBA Communications Stock Soars on Buyout Interest. What It Means for Tower Stocks. -- Barrons.com

9 abr 2026, 20:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

9 abr 2026, 19:30 UTC

Noticias de Eventos Importantes

How Digital Currencies Have Helped Iran -- WSJ

Comparación entre iguales

Cambio de precio

Avita Therapeutics Inc previsión

Precio Objetivo

By TipRanks

54.39% repunte

Estimación a 12 Meses

Media 6.33 USD 54.39%

Máximo 10 USD

Mínimo 3.5 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Avita Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Avita Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

8.83 / 9.77Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.